1. Conferences
  1. Keynote speakers

Keynote speakers

MIUA 2014 will include several keynote speeches from the following world-leading researchers:

Professor Dave Hawkes, University College London

Dave HawkesProfessor David Hawkes graduated from Oxford with a BA in Natural Sciences (Physics) in 1974 and obtained an MSc in Radiolobiology in Birmingham in 1975. His first post was as a clinical scientist in nuclear medicine at Southampton General Hospital. After obtaining his PhD in 1982 at the University of Surrey and the Institute of Cancer Research he spent seven years working as a clinical scientist at St. George's Hospital, London, before returning in 1988 to academia at the United Medical and Dental Schools of Guy's and St Thomas' Hospitals (UMDS), where he received a personal Chair in 1998.

Dave Hawkes is currently the Director of the Centre for Medical Image Computing, previously having been Director of the EPSRC and MRC funded Interdisciplinary Research Collaboration on Medical Images and Signals (MIAS-IRC), an £8M six year programme, from 2003 to 2007 and Chairman of the Division of Imaging Sciences at KCL (2002-2004). He spent 10 years working as a clinical scientist within the NHS before returning to academia. He is co-Founder of IXICO Ltd. (, a university spin-out that provides imaging solutions to the pharmaceutical industry. His current research interests encompass image matching, data fusion, visualisation, shape representation, surface geometry and modelling tissue deformation promoting medical imaging as an accurate measurement tool and image guided interventions.

He was elected FMedSci in 2011, FBIR in 2007, FREng in 2002, FInstP in 1997 and FIPEM in 1993. He became an NIHR Senior Investigator in 2009.

Professor Jean-Christophe Olivo-Marin, Institut Pasteur

Jean Christophe Olivo MarinJean-Christophe Olivo-Marin, PhD, is the head of the BioImage Analysis Unit and the chair of the Cell Biology and Infection Department at Institut Pasteur, Paris. He was a cofounder and Chief Technology Officer of the Institut Pasteur Korea, Seoul. His research interests are in image analysis of multidimensional microscopy images, computer vision and motion analysis for cellular dynamics, and in mathematical approaches for biological imaging. He is a Fellow of the IEEE, past Chair of the IEEE SPS Bio Imaging and Signal Processing Technical Committee (BISP-TC), a senior area editor of the IEEE Signal Processing Letters, and a member of the Editorial Board of the journals Medical Image Analysis and BMC Bioinformatics. He was the general chair of the IEEE International Symposium on Biomedical Imaging in 2008.

Professor Roger Gunn, Imperial College London

Roger GunnRoger Gunn (RG) is Chief Scientific Officer and Head of Analysis at Imanova, Professor of Molecular Neuroimaging in the Division of Brain Sciences at Imperial College London and Visiting Professor in the Department of Engineering at the University of Oxford. RG is an Applied Mathematician who received a PhD in bio-mathematical modelling of Positron Emission Tomography (PET) data from the University of Warwick in 1996. RG has worked on the development of quantitative mathematical techniques for the analysis of PET and MRI data and their application in studies of pathophysiology and drug development. RG has worked previously at the MRC Cyclotron Unit (UK), Montreal Neurological Institute (Canada) and GSK. In October 2011 he took up the position of Chief Scientific Officer at Imanova, which is a joint venture between the three major London universities (Imperial, UCL, Kings) and the MRC targeted at providing R&D imaging capabilities to the London Universities and Commercial organisations.

His research interests are focused on the application of mathematical biology and molecular imaging techniques to disease understanding and drug development in the neurosciences. RG has led the development of bio-mathematical tools for in silico screening of candidate imaging probes, quantitative analysis of dynamic PET data, measurement of BBB transport of drugs, PK/PD modelling of drug-target interactions, adaptive imaging study designs and characterization of novel PET tracers for a wide range of neurochemical targets including dopamine, serotonin, histamine, glycine, opioids, NK1, phosphodiesterase 4 and 10. RG has published over 120 peer reviewed journal articles in the field of imaging and has served on organising and programme committees at numerous conferences - he was recently Chair of BrainPET 2011 and organizer of the International PET Pharmacokinetics courses in 2010 & 2011.